Identification of -associated pneumonia cases among hospitalized patients using CLART® microarray technology.

Objectives: Community-acquired pneumonia (CAP) is a global health condition that affects populations from all age groups. The laboratory identification of as a causative agent of CAP is challenging because of its atypical and fastidious nature. Therefore, this study assessed the diagnostic potential of PneumoCLART bacteria® in identifying as a causative agent of pneumonia in hospitalized adults.